This study, called the Atlantic Lipid Lowering Treatment Optimization Program, is looking at a new way to help people with high cholesterol (hypercholesterolemia) manage their condition. It focuses on conditions like Familial Hypercholesterolemia and other types of high cholesterol. The study will use standard care but add special enhancements to reach high-risk patients early, including outreach and encouraging genetic testing. You might be able to join if you are between 18 and 120 years old and have high LDL-C (bad cholesterol) levels, a history of heart disease, or other specific risk factors. The main goal is to see if this approach can help lower and maintain your LDL-C below 100 mg/dL within 6 months. The current status of the study is unclear, but it plans to enroll 250 participants.

Study design

This is an interventional study that plans to enroll 250 participants. It will use a comprehensive outreach approach in conjunction with your primary care provider.

What's involved

The study involves screening for high LDL-C and evidence of familial hypertension. A study team member will reach out to inform you about the study and the consent process.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint for measuring LDL-C maintenance is at 6 months from enrollment in the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.